Some of the content on this page has been created using generative AI.
What is it about?
The study investigates the timing of clinical presentation of various types of Bacille Calmette-Guérin (BCG) infections in Finnish patients with bladder cancer treated with BCG instillation therapy. The study found that a pattern of early onset and late BCG infection subtypes may mostly be distinguished among systemic BCG infections, of which five of 39 (13%) presented after a latency of >1 year and 34/39 (87%) shortly after the last instillation. The study emphasized that most BCG infections occur during the first year after BCG instillations but should be suspected whenever a patient develops symptoms suggestive of tuberculosis, even after several years following BCG therapy.
Featured Image
Why is it important?
This study is important as it investigates the timing of clinical presentation of various types of BCG infections in a Finnish population of patients with bladder cancer treated with BCG instillation therapy. The results confirm the concept of early and late infection types, especially among systemic infections, and emphasize that urologists should be aware of the possibility of late BCG infection if patients develop symptoms even several years after the BCG regimen. This knowledge can help in the early diagnosis and treatment of BCG infections, which can improve patient outcomes. Key Takeaways: 1. The study identifies 100 patients with BCG infection during the study period, with 39% presenting as systemic infections and 61% in the genitourinary (GU) tract. 2. Systemic infections presented rapidly after the last instillation, while late infections (≥1 year) appeared to be rarer than previously described. 3. GU infections were more heterogeneous, with 20% presenting as late infections. 4. Most BCG infections occur during the first year after BCG instillations but should be suspected whenever a patient develops symptoms suggestive of tuberculosis, even after several years following BCG therapy.
AI notice
Read the Original
This page is a summary of: Clinical presentation of bacille Calmette–Guérin (BCG) infections after BCG instillation therapy, BJU International, August 2022, Wiley,
DOI: 10.1111/bju.15870.
You can read the full text:
Contributors
Be the first to contribute to this page







